Company / SG&A per Share
IDEAYA Biosciences, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.73
FY2025
5-year range
$0.34 / $0.73
FY2021-FY2025
Trend
+21.1%
vs FY2024
Sector context
#143 of 210
Health Care
What the data says
At $0.73, IDEAYA Biosciences, Inc.'s sg&a per share ranks #68 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $0.23 in FY2020 to $0.73 in FY2025.
Based on SEC 10-K filings.
0.73 in FY2025 with a 5-year CAGR of +26.1%.
Increased from $0.59 to $0.73 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +22.9%
- 5-Year CAGR
- +26.1%
- 10-Year CAGR
- -
Sector benchmark
#68 of 210 in Health CareTop 32% of 210This company $0.73 Sector average $29.50
▼
-97.5% below sector average
Key checks
Key Insights
- IDEAYA Biosciences, Inc.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 21.1% year-over-year.
- Ranks #143 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.73 | +21.1% |
| FY2024 | $0.60 | +2.9% |
| FY2023 | $0.59 | +49.1% |
| FY2022 | $0.39 | +17.0% |
| FY2021 | $0.34 | +46.8% |
| FY2020 | $0.23 | -71.2% |
| FY2019 | $0.80 | -83.7% |
| FY2018 | $4.88 | +65.3% |
| FY2017 | $2.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026